Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-750-5 | CAS number: 693-36-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The test substance was found to cause no mortality upon acute oral and dermal exposure to rats of 5000 and 2000 mg/kg bw, respectively. Similarly, no mortality was observed in rats in the acute oral toxicity study with 5000 mg/kg bw of the C12-analogue. No findings were noted regarding body weight development or gross pathology. Transient mild clinical signs resolved within the observation period. All three studies are adequately reported and in their design equivalent or similar to the respective OECD testing guidelines.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1975-10
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- yes
- Remarks:
- Limited details on test design and observations were reported. Body weight not recorded, no individual data
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: In house bred
- Age at study initiation: 7 -8 weeks
- Weight at study initiation: 265 g (males); 167 g (females)
- Housing: Individually
- Diet: Ad libitum, commercial pelleted diet (Oakes Special Diet with added Vit. E)
- Water: Ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 2
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- other: 50 % aqueous solution of polyethylene glycol
- Doses:
- A 25 % (w/v) solution of the compound in a 50 % aqueous solution of polyethylene glycol was administered as a single dose to rats which had been fasted for 18 hours, at a rate of 20 mL/kg (equivalent to 5 g compound/kg).
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- >= 5 000 mg/kg bw
- Mortality:
- No deaths occurred during the 14 day observation period.
- Clinical signs:
- other: No clinical symptoms were recorded
- Gross pathology:
- At autopsy no changes in organs or tissues caused by the administration of the test compound were seen.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute oral median lethal dose (LD50) of the test article in rats is greater than 5 g/kg body weight. No clinical symptoms were recorded and no deaths occurred during the 14 day observation period.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1992-04-28 - 1992-06-04
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Tif: RAI f (SPF)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: CIBA-GEIGY Ltd., Animal Production, Stein, Switzerland
- Weight at study initiation: 201 - 286 g
- Housing: Individually in Macrolon cages type 3, with standardized soft wood bedding (Societe Parisienne des Sciures, Pantin, France)
- Diet: Ad libitum, NAFAG 890 Tox, NAFAG, Gossau/SG, Switzerland
- Water: Ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2
- Humidity (%): 55 ± 10
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12 - Type of coverage:
- semiocclusive
- Vehicle:
- arachis oil
- Details on dermal exposure:
- TEST SITE
- Area of exposure: Back
- % coverage: About 10% of the body surface
- Type of wrap if used: gauze-lined semiocclusive dressing fastened around the trunk with an adhesive elastic bandage
REMOVAL OF TEST SUBSTANCE
- Washing (if done): With lukewarm water
- Time after start of exposure: 24 h
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 4 g (corresponding to approx. 4 ml)
- Constant volume or concentration used: yes
- For solids, paste formed: yes - Duration of exposure:
- 24 h
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Signs and symptoms (daily); mortality (twice a day); body weight (immediately before application and on days 7 and 14)
- Necropsy of survivors performed: yes
- Other examinations performed: The animals were submitted to a gross necropsy at the end of the observation period. - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- >= 2 000 mg/kg bw
- Mortality:
- No mortalities occurred in this study.
- Clinical signs:
- other: Piloerection, hunched posture, and dyspnea were seen, being common symptoms in acute dermal tests. The animals recovered within 2 to 3 days.
- Gross pathology:
- No deviations from normal morphology were found.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test item is not toxic upon dermal application to rats.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Oral Toxicity
In the key study each five male and female Sprague-Dawley rats were given a single gavage dose of 5000 mg/kg bw in 50% polyethylene glycol. No clinical symptoms were recorded and no deaths occurred during the 14 day observation period. At autopsy no changes in organs or tissues caused by the administration of the test compound were seen. This study contains less detail on experimental performance than the second study with a structural analogue but is otherwise considered adequate for hazard assessment.
The findings of the key study are consistent with the results of a second acute oral toxicity study performed with a structural analogue. This study was performed and reported similar to the requirements of OECD testing guideline 423. It was performed prior to the introduction of GLP. The test item is an analogue substance that differs in having two C12 alkyl chains instead of two C18 alkyl chains. The shorter alkyl chain is expected to result in slightly more favourable solubility and absorption after uptake. Considering the 1.3 fold difference in molecular weight, application of the C12 analogue results in a higher number of molecules so that overall, any hazard identified for the analogue is considered relevant for the target substance. The read-across study was performed in five male and five female Tif:RAIf(SPF) rats with a limit dose of 5000 mg/kg bw that was applied by gavage using CMPS80 as vehicle. No mortality occurred. Dyspnea was observed between day 1 and day 10; ruffled fur between day 1 and day 9; body position-curved between day 1 and 6. The animals recovered within 11 days.
Dermal Toxicity
The key study for acute dermal toxicity was performed with a well-characterized test material according to GLP and a protocol similar to OECD Guideline 402. In this study the substance was applied as a paste in arachis oil to the skin of 5 male and 5 female rats (Tif: RAIf (SPF) at a dose of 2000 mg/kg bw and covered with a semi-occlusive dressing for 24 hours. There were no deaths during the 14-day observation period. Piloerection, hunched posture, and dyspnea were seen. The animals recovered within 2 to 3 days. No deviations from normal morphology were found upon necropsy. The LD50was higher than 2000 mg/kg bw.
InhalationToxicity
No experimental data is available regarding acute inhalation toxicity.
Justification for classification or non-classification
Classification, Labeling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. As a result the substance is not considered to be classified for acute toxicity under Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.